AstraZeneca pays up to $1bn for biotech firm 'that could transform cell therapy'

Retrieved on: 2025-03-17 14:16:09

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca pays up to $1bn for biotech firm 'that could transform cell therapy'. View article details on hiswai:

Excerpt

AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of ...

Article found on: www.theguardian.com